Summary: Nebulization is gaining popularity as a treatment alternative ... Nebulized magnesium sulfate can be used in managing acute asthma and is given in dosages between 125 and 250 mg every ...

An albuterol/budesonide fixed-dose combination rescue medication has been shown to reduce severe exacerbations in patients with asthma for the first time, according to positive Phase 3 trial ...

Asthma is a chronic (long-term) lung condition in which airways can become inflamed and narrowed. This makes it difficult to ...

The U.S. Centers for Medicare & Medicaid Services (CMS) has released a preliminary list of 101 generic drugs that would be ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...

AstraZeneca's Airsupra (albuterol/budesonide) met the primary endpoint in the Phase III BATURA trial, significantly reducing ...

Rescue medications that provide fast relief of acute asthma symptomsMedically reviewed by Corinne Savides Happel, MDMedically ...

Treatment with oral or inhaled corticosteroids is not warranted for children without history of atopy or family history of asthma ... received albuterol plus a 7-day course of inhaled budesonide ...

AstraZeneca’s BATURA phase IIIb trial of Airsupra in patients with intermittent or mild persistent asthma meets primary endpoint: Cambridge, UK Tuesday, October 8, 2024, 09:00 H ...

In the phase 3b BATURA trial, Airsupra—a pressurized metered-dose inhaler containing albuterol and budesonide—significantly ...

AstraZeneca's inhaled rescue medication, Airsupra (albuterol/budesonide), has shown significant efficacy in reducing the risk ...

Topline results were announced from a trial evaluating albuterol/budesonide inhaler in patients with intermittent or mild persistent asthma.